News and Updates

As Breakthrough T1D’s largest corporate partner, Marshalls has raised more than $47 million to-date to improve and change life with type 1 diabetes.

Hy-Vee has been a trusted partner of Breakthrough T1D since 1988, raising nearly $20 million through corporate and store events.

Since 1994, Wawa has raised millions of dollars for type 1 diabetes research through in-store fundraising campaigns across the Eastern U.S.

Breakthrough T1D’s newest publication outlines a roadmap for beta cell replacement therapies for type 1 diabetes.

The Udaipur Type 1 Diabetes Summit gathered international leaders to develop a collaborative roadmap for strengthening T1D care across India.

Check out Breakthrough T1D's ADA 2025 coverage of cutting-edge T1D updates in cures, improving lives, and clinical adoption.

Medical Affairs (+Research and Advocacy) Breakthrough T1D’s Medical Affairs program is bridging the gap between access to and adoption of therapies, treatments, drugs, and devices for T1D. To accomplish this goal, the Medical Affairs team is working on healthcare provider (HCP) education, development of clinical care guidelines, and clinical trial education and awareness. Breakthrough T1D’s […]

Breakthrough T1D was in Chicago, IL for ADA 2025. Here we report on the latest advancements in cures for type 1 diabetes.

Improving Lives Breakthrough T1D’s Improving Lives program focuses on devices, insulins, adjunctive therapies, treatments for complications, and psychosocial interventions to improve the health and quality of life of people living with T1D. Adjunctive therapies and complications There was significant focus on GLP-1 receptor agonists (GLP-1RAs) and SGLT inhibitors (SGLTi) in reducing long-term complications and improving […]

Breakthrough T1D is heading to Chicago, IL to attend the 2025 ADA conference from June 20-23 to discuss cutting-edge type 1 diabetes updates.